Dataset from A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00012120
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of this study is to determine whether Nivolumab will improve disease-free survival compared with placebo.
创建时间：
2026-04-05
